The Mary Tyler Moore Vision Initiative

Join us in honoring Mary Tyler Moore by supporting our mission to end vision loss and blindness from diabetes.

Our Purpose

Welcoming Regeneron and Adaptive Sensory Technology

Our Consortium Is Growing

Welcoming Regeneron and Adaptive Sensory Technology

The Mary Tyler Moore Vision Initiative is proud to welcome Regeneron as a Founding Member and Adaptive Sensory Technology (AST) as a Device Member of the MTM Vision Consortium. Joining our first founding member, Boehringer Ingelheim, these new members bring complementary expertise to our growing collaboration, strengthening our joint efforts to accelerate research and innovation toward a world without vision loss and blindness from diabetes.

View the full press release here

1 Billion

people with diabetes by 2050 and at risk of vision loss and blindness

The Mary Tyler Moore Vision Initiative (MTM Vision) is a one-of-a-kind non-profit uniting the world in the fight against diabetes-related vision loss and blindness. MTM Vision enables significant research breakthroughs and supports global scientific collaboration to realize Mary’s dream of a world without vision loss and blindness from diabetes.

MTM Vision brings together global leaders and innovators from diverse fields, including universities, pharmaceutical and medical device companies, government agencies, tech firms, the entertainment industry, and people and families with diabetes, all to advance research for a cure for diabetic retinal disease.

OUR PURPOSE

Mary Tyler Moore  vision initiative

Ocular Biorepository and Resource Center

Our Mission

To provide the scientific community with an essential tool to develop new diagnostics and treatment options for people with diabetic retinal disease (DRD)

Learn More